B.E. Souberbielle

709 total citations
27 papers, 553 citations indexed

About

B.E. Souberbielle is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, B.E. Souberbielle has authored 27 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in B.E. Souberbielle's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (4 papers). B.E. Souberbielle is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (4 papers). B.E. Souberbielle collaborates with scholars based in United Kingdom, United States and Switzerland. B.E. Souberbielle's co-authors include Mary O’Brien, R. Mendes, Angus Dalgleish, Ian E. Smith, Michael Westby, Joanna Galea‐Lauri, B. Knight, W J Morrow, Tristan Wagner and D. F. Young and has published in prestigious journals such as Journal of Virology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

B.E. Souberbielle

27 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.E. Souberbielle United Kingdom 16 321 189 143 85 60 27 553
Antonio Scardino France 15 608 1.9× 183 1.0× 362 2.5× 100 1.2× 31 0.5× 18 758
Pankita H. Pandya United States 9 143 0.4× 145 0.8× 165 1.2× 62 0.7× 82 1.4× 20 475
Giancarlo Pizza Italy 12 148 0.5× 114 0.6× 64 0.4× 142 1.7× 61 1.0× 22 435
Renzo Perales‐Linares United States 7 207 0.6× 202 1.1× 259 1.8× 65 0.8× 48 0.8× 10 517
Laura A. Vella United States 12 329 1.0× 95 0.5× 157 1.1× 97 1.1× 37 0.6× 19 609
Clive R.D. Carter United Kingdom 8 355 1.1× 196 1.0× 123 0.9× 32 0.4× 47 0.8× 11 541
Chang You Wu Canada 5 463 1.4× 94 0.5× 72 0.5× 73 0.9× 36 0.6× 7 653
Kevin D. Cook United States 13 560 1.7× 180 1.0× 237 1.7× 90 1.1× 25 0.4× 23 815
Joseph W. Maciaszek United States 7 521 1.6× 108 0.6× 125 0.9× 81 1.0× 16 0.3× 10 682
Angelika Schlamp Germany 7 384 1.2× 104 0.6× 149 1.0× 29 0.3× 16 0.3× 9 482

Countries citing papers authored by B.E. Souberbielle

Since Specialization
Citations

This map shows the geographic impact of B.E. Souberbielle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.E. Souberbielle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.E. Souberbielle more than expected).

Fields of papers citing papers by B.E. Souberbielle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.E. Souberbielle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.E. Souberbielle. The network helps show where B.E. Souberbielle may publish in the future.

Co-authorship network of co-authors of B.E. Souberbielle

This figure shows the co-authorship network connecting the top 25 collaborators of B.E. Souberbielle. A scholar is included among the top collaborators of B.E. Souberbielle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.E. Souberbielle. B.E. Souberbielle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huizinga, T., Anastas Batalov, Румен Стоилов, et al.. (2017). Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Research & Therapy. 19(1). 53–53. 30 indexed citations
3.
Souberbielle, B.E., et al.. (2009). A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurologica Scandinavica. 82(5). 303–310. 12 indexed citations
4.
Mendes, R., Mary O’Brien, Abhishek Mitra, et al.. (2002). Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma. British Journal of Cancer. 86(3). 336–341. 18 indexed citations
5.
6.
O’Brien, Mary, Andrea Saini, Ian E. Smith, et al.. (2000). A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. British Journal of Cancer. 83(7). 853–857. 66 indexed citations
7.
Hrouda, David, et al.. (2000). Allogeneic whole‐tumour cell vaccination in the rat model of prostate cancer. British Journal of Urology. 86(6). 742–748. 26 indexed citations
8.
Mendes, R., Michael Westby, Joanna Galea‐Lauri, et al.. (2000). Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood. Cytometry. 39(1). 72–78. 51 indexed citations
9.
Mendes, R., et al.. (1999). A whole blood facscan assay to look at cytokine production by NK cells in cancer patients.. British Journal of Cancer. 80. 85–85. 15 indexed citations
10.
Souberbielle, B.E., et al.. (1999). Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine. Gene Therapy. 6(8). 1475–1481. 49 indexed citations
11.
Al‐Moundhri, Mansour, et al.. (1998). Immunotherapy in lung cancer. British Journal of Cancer. 78(3). 282–288. 20 indexed citations
12.
Souberbielle, B.E., et al.. (1998). Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model. Gene Therapy. 5(11). 1447–1454. 18 indexed citations
13.
Galea‐Lauri, Joanna, et al.. (1998). A highly sensitive whole blood natural killer cell assay. Journal of Immunological Methods. 217(1-2). 177–184. 15 indexed citations
14.
Souberbielle, B.E., et al.. (1997). Lack of T Cell Response to Cardiac Myosin and a Reduced Response to PPD in Patients with Idiopathic Dilated Cardiomyopathy. Journal of Autoimmunity. 10(2). 219–227. 4 indexed citations
15.
Knight, B., B.E. Souberbielle, Gian Paolo Rizzardi, Sarah E. Ball, & Angus Dalgleish. (1996). Allogeneic murine melanoma cell vaccine. Melanoma Research. 6(4). 299–306. 35 indexed citations
16.
17.
Souberbielle, B.E., et al.. (1994). In vitro HIV1 infection of human cervical tissue. Research in Virology. 145(3-4). 155–161. 31 indexed citations
18.
Souberbielle, B.E., Robert Swingler, D. Davidson, et al.. (1992). Western blotting analysis in patients with MS using human brain vessels as antigen. Acta Neurologica Scandinavica. 86(4). 397–402. 7 indexed citations
19.
O’Brien, Mary & B.E. Souberbielle. (1992). Review: Allergic reactions to cytotoxic drugs - an update. Annals of Oncology. 3(8). 605–610. 16 indexed citations
20.
Young, D. F., et al.. (1990). Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. Journal of Virology. 64(11). 5403–5411. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Scardino Breakdown of academic impact, for papers by Pankita H. Pandya Breakdown of academic impact, for papers by Giancarlo Pizza Breakdown of academic impact, for papers by Renzo Perales‐Linares Breakdown of academic impact, for papers by Laura A. Vella Breakdown of academic impact, for papers by Clive R.D. Carter Breakdown of academic impact, for papers by Chang You Wu Breakdown of academic impact, for papers by Kevin D. Cook Breakdown of academic impact, for papers by Joseph W. Maciaszek Breakdown of academic impact, for papers by Angelika Schlamp
Rankless by CCL
2026